Abstract
We present herein the combined effect of our specially designed laser, magnetic and microwave therapeutic influence on the physiology of the osteoporosis patient. In our age of improved average life expectancy, even some partial cure of osteoporosis remains as a pressing issue, particularly in the light of the growing number of osteoporosis related fractures with still more rapidly growing costs of treatment which is usually accompanied with no less harmful side effects leading to deterioration in the affected patient’s general quality of life (QOL). The author analyzed 180 cases of osteoporosis patients undergoing treatment in the Clinic from 1999 till 2006. We used bone densitometry data obtained by Dual-Energy-X-ray Absorptiometry (DEXA) as the treatment effectiveness criteria. Without any additional medication, we applied various laser, magnetic and microwave influences to treat the disease. The diagnostics and treatment methodology, developed by the author, is based on the principle of treating the whole body as a system and the organic etiopathogenesis of the specific disease, osteoporosis, in particular. The results of the osteodensitometry have been analyzed in terms of the type of osteoporosis, sex, time of treatment, stage of osteoporosis, and the type of bone tissue. Therapy for osteoporosis in our Clinic leads to a significant increase in bone mineral density (BMD) for all types of osteoporosis, with a substantial increase in the bone mass within a period about six months after the completion of the treatment. The bone-mass increase correlated with the positive dynamics of the bone metabolism markers, namely cross-laps and osteocalcin. Analgesic effects were analyzed according to two scales: the verbal ranking scale and the visual analog scale (VAS). Pain intensity decreased by 75%. None of our patients developed any fresh fractures during the course of 5 years subsequent to the treatment. The combination of the therapeutic strategies and the system itself allows the Clinic provide the best possible medical care for osteoporotic patients, by increasing the bone mass and BMD, reducing the pain syndrome, and substantially reducing the chances of fractures, thus improving the QOL and life expectancy of the osteoporosis patient.
